Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors - Concepedia

Concepedia

Publication | Open Access

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

DOI Full Paper Access

81

Citations

21

References

2018

Year

Ben Tran, Richard D. Carvajal, Aurélien Marabelle, Sandip Pravin Patel, Patricia LoRusso, Erik Rasmussen, Gloria Juan, Vijay Upreti, Courtney Beers, Gataree Ngarmchamnanrith,

Journal for ImmunoTherapy of Cancer

Abstract

ClinicalTrials.gov, NCT02437916 .

References

	Year	Citations

Page 1